Published in Vaccine on December 27, 2012
The prospects and challenges of universal vaccines for influenza. Trends Microbiol (2013) 0.97
M2e-Based Universal Influenza A Vaccines. Vaccines (Basel) (2015) 0.93
Advancements in the development of subunit influenza vaccines. Microbes Infect (2014) 0.82
Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice. Virol J (2014) 0.78
Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella. Protein Sci (2017) 0.75
Presenting Influenza A M2e Antigen on Recombinant Spores of Bacillus subtilis. PLoS One (2016) 0.75
Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7. PLoS One (2017) 0.75
Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate. Antiviral Res (2017) 0.75
Detection by RT-PCR and genetic characterization of canine distemper virus from vaccinated and non-vaccinated dogs in Argentina. Vet Microbiol (2007) 1.13
First isolation of an H1N1 avian influenza virus from wild terrestrial non-migratory birds in Argentina. Virology (2009) 1.00
Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine (2008) 0.91
Crystallographic studies on decameric Brucella spp. Lumazine synthase: a novel quaternary arrangement evolved for a new function? J Mol Biol (2005) 0.91
An atypical riboflavin pathway is essential for Brucella abortus virulence. PLoS One (2010) 0.91
The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams. Vaccine (2009) 0.90
Molecular characterization of canine parvovirus strains in Argentina: Detection of the pathogenic variant CPV2c in vaccinated dogs. J Virol Methods (2009) 0.90
Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Vaccine (2005) 0.89
HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine (2010) 0.88
Evolution of canine parvovirus in Argentina between years 2003 and 2010: CPV2c has become the predominant variant affecting the domestic dog population. Virus Res (2011) 0.88
Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine (2010) 0.88
Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice. J Immunol (2013) 0.86
Genetic characterization of South American infectious bursal disease virus reveals the existence of a distinct worldwide-spread genetic lineage. Avian Pathol (2015) 0.85
Structural and kinetic properties of lumazine synthase isoenzymes in the order Rhizobiales. J Mol Biol (2007) 0.83
New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis. Arch Med Res (2002) 0.83
Quantitative single serum-dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and expected protection against foot-and-mouth disease virus in vaccinated cattle. J Virol Methods (2010) 0.83
Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams. Vet Immunol Immunopathol (2013) 0.82
HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice. Mol Ther (2012) 0.81
Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera. Infect Immun (2014) 0.80
Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies. Vet Microbiol (2008) 0.79
Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region. Vaccine (2011) 0.79
The vaccine candidate BLSOmp31 protects mice against Brucella canis infection. Vaccine (2013) 0.78
Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant. New Microbiol (2013) 0.77
Improved immune response to recombinant influenza nucleoprotein formulated with ISCOMATRIX. J Microbiol Biotechnol (2012) 0.77
Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus. Vet Microbiol (2013) 0.77
Study of canine parvovirus evolution: comparative analysis of full-length VP2 gene sequences from Argentina and international field strains. Virus Genes (2011) 0.76
First full-length genomic sequence of a hepatitis A virus isolated in Argentina shows recombination between subgenotypes IA and IB. Virus Res (2010) 0.76
Infection rates in Dipetalogaster maximus (Reduviidae: Triatominae) by Trypanosoma cruzi in the Cape Region, Baja California Sur, México. J Med Entomol (2003) 0.76
Characterization of infectious bursal disease viruses from Argentina. Avian Dis (2006) 0.75
Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region. Vet Microbiol (2012) 0.75
Foot-and-mouth disease polyvalent oil vaccines inoculated repeteadly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays. Vaccine (2004) 0.75
Identification, molecular and phylogenetic analysis of poxvirus in skin lesions of southern right whale. Dis Aquat Organ (2015) 0.75